EFDID: 540109EFD: View Filing

Issuer: Olema Pharmaceuticals, Inc. (0001750284) - D

Accession: 0001243233-24-000002 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
  • Entity Name:
    Olema Pharmaceuticals, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    780 BRANNAN STREET
    SAN FRANCISCO, CA 94103
  • Persons:
    Related Persons 13
    Sean Bohen, M.D., Ph.D.
    Executive Officer, Director
    David C. Myles, Ph.D.
    Executive Officer
    Shane Kovacs
    Executive Officer
    Naseem Zojwalla, M.D.
    Executive Officer
    Yi Larson
    Director
    Andrew Rappaport
    Director
    Cynthia Butitta
    Director
    Cyrus L. Harmon, Ph.D.
    Director
    Sandra Horning, M.D.
    Director
    Gorjan Hrustanovic, Ph.D.
    Director
    Graham Walmsley, M.D., Ph.D.
    Director
    Ian Clark
    Director
    Scott Garland
    Director
EDGAR: Offering Information
  • Accession Date:
    12/11/2024
  • First Sale Date:
    12/04/2024
  • Offering Amount:
    $249,999,986
  • Amount Sold:
    $249,999,225
  • Amount Remaining:
    $761
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    The Total Offering Amount and Total Amount Remaining to be Sold include amounts that may be received by the Issuer upon exercise of pre-funded warrants at an exercise price of $0.0001 per pre-funded warrant.
EFD: Current State Notices

Notices found in EFD

Filed:CA, CT, MA, NY
Inactive:CO, IL
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Jefferies LLC 2347 None None All States
J.P. Morgan Securities LLC 79 None None All States
Goldman Sachs & Co. LLC 361 None None All States
LifeSci Capital LLC 168404 None None All States
Oppenheimer & Co. Inc. 249 None None All States
H.C. Wainright & Co., LLChow 375 None None All States
Citigroup Global Markets Inc. 7059 None None All States
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Olema Pharmaceuticals, Inc./s/ Shane KovacsShane KovacsChief Operating and Financial Officer2024-12-11